Sorbent for endotoxins

US9440019B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9440019-B2
Application numberUS-201113806184-A
CountryUS
Kind codeB2
Filing dateJun 22, 2011
Priority dateJun 24, 2010
Publication dateSep 13, 2016
Grant dateSep 13, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention relates to a sorption agent for removing endotoxins from a biological fluid, comprising a water-insoluble, porous carrier having a neutral hydrophobic surface wherein the surface of the carrier has an adsorptive coating made of polymyxin and albumin, wherein polymyxin and albumin are bonded to the surface of the carrier in a noncovalent manner. The invention further relates to a method for producing such a sorption agent. The sorption agent is used in extracorporeal blood purification, in particular in order to treat individuals, who have sepsis.

First claim

Opening claim text (preview).

The invention claimed is: 1. A sorption agent for removing endotoxins from blood or blood plasma, comprising: a water-insoluble, porous carrier having a neutral hydrophobic surface wherein the surface of the carrier has an adsorptive coating made of polymyxin B and human serum albumin, wherein the polymyxin B and human serum albumin are noncovalently attached to the surface of the carrier by a hydrophobic interaction. 2. The sorption agent according to claim 1 , wherein the carrier is a hydrophobic polymer. 3. The sorption agent according to claim 2 , wherein the hydrophobic polymer is a cross-linked polystyrene polymer. 4. The sorption agent according to claim 1 , wherein the carrier has a mean pore size of at least 15 nm. 5. The sorption agent according to claim 1 , wherein the carrier has a mean pore size of not greater than 120 nm. 6. The sorption agent according to claim 1 , wherein the sorption agent has the form of microparticles. 7. The sorption agent according to claim 6 , wherein the microparticles have a particle size of 20 μm or less. 8. A sorption apparatus, containing the sorption agent according to claim 1 . 9. A plasma circuit, containing a suspension of the sorption agent according to claim 1 . 10. A method of producing a sorption agent according to claim 1 , comprising the steps of: a) providing a water-insoluble, porous carrier which has a neutral, hydrophobic surface, b) adsorptively coating the surface of the carrier with polymyxin B by contacting and incubating the carrier with an aqueous, polymyxin B-containing solution, c) washing the carrier to remove any unbound polymyxin B, d) adsorptively coating the polymyxin B-coated surface of the carrier with human serum albumin by contacting and incubating the carrier with an aqueous, human serum albumin-containing solution, and e) as appropriate, washing the carrier to remove any unbound human serum albumin. 11. The method according to claim 10 , wherein the carrier is autoclaved between the steps b) and c) or between the steps c) and d). 12. A method for removing endotoxins from blood or blood plasma, comprising: bringing blood or blood plasma contaminated with endotoxins into contact with the sorption agent according to claim 1 . 13. The method according to claim 12 , carried out for the treatment of a sepsis. 14. The method according to claim 12 , wherein the sorption agent is included in a Microspheres-based Detoxification System (MDS). 15. The sorption agent according to claim 3 , wherein the hydrophobic polymer is a polystyrene-divinyl benzene copolymer. 16. The sorption agent according to claim 4 , wherein the carrier has a mean pore size of at least 30 nm. 17. The sorption agent according to claim 7 , wherein the microparticles have a particle size of 8 μm or less. 18. The sorption agent according to claim 7 , wherein the microparticles have a particle size of 5 μm or less.

Assignees

Inventors

Classifications

  • Proteins, nucleic acids, polysaccharides, antibodies or antigens · CPC title

  • consisting of a polymer obtained by reactions involving only carbon to carbon unsaturated bonds · CPC title

  • Cross-linked polymers · CPC title

  • comprising a cyclic structure containing at least one of the heteroatoms nitrogen, oxygen or sulfur, e.g. heterocyclic or heteroaromatic structures · CPC title

  • the functional group or the linking, spacer or anchoring group as a whole comprising at least one type of heteroatom selected from a nitrogen, oxygen or sulfur, these atoms not being part of the carrier as such · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9440019B2 cover?
The invention relates to a sorption agent for removing endotoxins from a biological fluid, comprising a water-insoluble, porous carrier having a neutral hydrophobic surface wherein the surface of the carrier has an adsorptive coating made of polymyxin and albumin, wherein polymyxin and albumin are bonded to the surface of the carrier in a noncovalent manner. The invention further relates to a m…
Who is the assignee on this patent?
Falkenhagen Dieter, Harm Stephan, Hartmann Jens, and 2 more
What technology area does this patent fall under?
Primary CPC classification A61M1/3472. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Sep 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).